Open this publication in new window or tab >>Karolinska Inst, Dept Clin Sci Intervent & Technol CLINTEC, Huddinge, Sweden..
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Immunology, Genetics and Pathology, Cancer Immunotherapy. Univ Bergen, Ctr Canc Biomarkers CCBIO, Dept Clin Med, Bergen, Norway..
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Immunology, Genetics and Pathology, Cancer Immunotherapy.
Karolinska Inst, Dept Clin Sci Intervent & Technol CLINTEC, Huddinge, Sweden..
Karolinska Inst, Dept Clin Sci Intervent & Technol CLINTEC, Huddinge, Sweden..
Karolinska Inst, Dept Clin Sci Intervent & Technol CLINTEC, Huddinge, Sweden..
Karolinska Inst, Dept Clin Sci Intervent & Technol CLINTEC, Huddinge, Sweden..
Karolinska Inst, Dept Med, Huddinge MedH, Huddinge, Sweden..
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Immunology, Genetics and Pathology, Neurooncology and neurodegeneration.
Karolinska Inst, Dept Med, Huddinge MedH, Huddinge, Sweden..
Karolinska Univ Hosp, Dept Clin Pathol & Canc Diagnost, Stockholm, Sweden..
Karolinska Inst, Dept Clin Sci Intervent & Technol CLINTEC, Huddinge, Sweden..
Karolinska Inst, Dept Clin Sci Intervent & Technol CLINTEC, Huddinge, Sweden..
Karolinska Inst, Dept Clin Sci Intervent & Technol CLINTEC, Huddinge, Sweden..
Karolinska Inst, CRISPR Funct Genom, SciLifeLab, Solna, Sweden.;Karolinska Inst, Dept Med Biochem & Biophys, Solna, Sweden..
Karolinska Inst, CRISPR Funct Genom, SciLifeLab, Solna, Sweden.;Karolinska Inst, Dept Med Biochem & Biophys, Solna, Sweden..
Karolinska Inst, CRISPR Funct Genom, SciLifeLab, Solna, Sweden.;Karolinska Inst, Dept Med Biochem & Biophys, Solna, Sweden..
Karolinska Univ Hosp, Dept Clin Pathol & Canc Diagnost, Stockholm, Sweden..
Karolinska Inst, Dept Clin Sci Intervent & Technol CLINTEC, Huddinge, Sweden.;Karolinska Univ Hosp, Dept Clin Pathol & Canc Diagnost, Stockholm, Sweden.;Karolinska Inst, Dept Lab Med, Div Pathol, Stockholm, Sweden..
Karolinska Inst, Dept Clin Sci Intervent & Technol CLINTEC, Huddinge, Sweden.;Karolinska Univ Hosp, Theme Canc, Solna, Sweden..
Show others...
2025 (English)In: Nature Communications, E-ISSN 2041-1723, Vol. 16, article id 8307Article in journal (Refereed) Published
Abstract [en]
Pancreatic cancer is an aggressive disease with a dense fibrotic stroma and is often accompanied by chronic inflammation. Peritumoral inflammation is typically viewed as a reaction to nearby tumor growth. Here, we report that the inflamed pancreatic lobules are frequently invaded by tumor cells, forming a distinct, non-fibrotic tumor niche. Using a semi-supervised machine learning approach for annotations of clinical samples and multiplex protein profiling, we show that tumor cells at the invasion front are closely associated with acinar cells undergoing damage-induced changes, and with activated fibroblasts expressing markers of injury. The invaded lobules are linked to classical tumor phenotypes, in contrast to fibrotic areas where tumor cells display a more basal profile, highlighting microenvironment-dependent tumor subtype differences. In female mice, lobular invasion similarly aligns with the classical tumor phenotype. Together, our data reveal that pancreatic tumors colonize injured lobules, creating a unique niche that shapes tumor characteristics and contributes to disease biology.
Place, publisher, year, edition, pages
Springer Nature, 2025
National Category
Cancer and Oncology Cell and Molecular Biology
Identifiers
urn:nbn:se:uu:diva-569962 (URN)10.1038/s41467-025-63864-7 (DOI)001582507700006 ()41006303 (PubMedID)2-s2.0-105017414928 (Scopus ID)
Funder
Karolinska InstituteSwedish Research Council, 2018-02023Swedish Research Council, 2024-03026Swedish Cancer Society, 22 2175 PjSwedish Cancer Society, 23 2856 PjRegion StockholmSwedish National Infrastructure for Computing (SNIC)Swedish Society for Medical Research (SSMF), PD21-0114The Cancer Research Funds of RadiumhemmetBengt Ihres FoundationRuth and Richard Julin Foundation
2025-10-202025-10-202025-10-20Bibliographically approved